Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: dizziness; blurred vision; weakness in arms and legs, general weakness; feeling and been sick; Headache; This is a spontaneous report from a contactable consumer received from the Regulatory Agency (RA). The regulatory authority report number is GB-MHRA-WEBCOVID-202106041541367510-NKNR5. Safety Report Unique Identifier GB-MHRA-ADR 25421522. A 20-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 31May2021 as single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. He has not had symptoms associated with COVID-19 and not enrolled in clinical trial. The patient experienced dizziness and blurred vision on an unspecified date; headache on 03Jun2021. Case narrative: headache, weakness in arms and legs, blurred vision, feeling and been sick, general weakness, and dizziness, all lasting so random 15-minute period 4 days after the vaccine. No relevant investigations or tests conducted. He has not tested positive for COVID-19 since having the vaccine. He underwent lab tests and procedures which included COVID-19 virus test: no - negative COVID-19 test on 03Jun2021. The patient recovered from all events on 03Jun2021. Case was reported as medically significant by health authority. No follow-up attempts are possible; information about lot/batch number cannot be requested.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166